Research News

Posted on 11 December 2017

Share

Some news into very early-stage research into Tourettes Syndrome from the USA in regards to drug treatment which may have future potential to be useful in a wide range of neurological diseases.

A company called Abide Therapeutics found in an early phase of an exploratory study that results indicated a positive impact on key measures of TS symptoms. We look forward to hearing more results from this trial which may lead to drug development in the future. Read more HERE.

Return to news